Monthly Archives May 2018

Click here to read the notification from Pfizer dated 30 May 2018. Existing stock in the supply chain will be placed on allocation in an attempt to ensure supplies are available for a reasonable period of time leading to the availability of Section 29 product late June 2018. Should you have special needs that exceed this allocation then you will…

This deal is well worth your consideration. This is a reminder to consider purchasing some extra stock to take full advantage of this GSK Deal. It may not be repeated for a month or more. Note that the deal ends 31 May 2018. Late orders will not qualify. Click here for the order form or access it directly from the…

Click here to access a full list of price changes set to be implemented 1 July 2018 in the Pharmaceutical Schedule. Price Increases (these are few and far between) we try to avoid implementation prior to 1 July 2018, however if our stocks are depleted and on re-ordering the manufacturer charges the new price (which they are entitled to do…

The following product(s) are being reference priced from 1 June 2018, which comes about from an alternative being award the Sole Supply within the next few months. We are highlighting these so that you have time to manage the transition. No price support provided for the following therefore price will not be reduced until stocks in the supply chain currently…

Click here to read the latest notification from Aspen relating to supply issues around Marcain and Xylocaine. For previous information please feel free to search Mind Time, where you will find all other related data.

As per Pharmaceutical Schedule Update for June 2018, there is to be a major change in pricing for both of the Atripla Tab and Truvada Tab as follows. Atripla Tab 30         Pharmacode 2427095     Current Schedule Price $1313.19 New Schedule price effective 22 June 2018 $237.52 Truvada Tab 30      Pharmacode 2427109     Current Schedule Price $838.20 New Schedule price effective…

As advised via PHARMAC tender of 30 November 2017 there is to be a change in the listing and future sole supply. New listing from 1 June 2018 Imiquimod-Perrigo Crm 5% 250 mg sachet 24 pk   Pharmacode  2543907 Schedule price $21.72 Incumbent brand Imiquimod-Apo Crm 5% 250 mg sachet 12 p                        Pharmacode 2470993 Schedule price $17.98 Reference pricing will apply…

Click here to read the Pfizer notification advising of a resumption of supply. The Section 29 listing will be delisted in due course Vinblastin Teva Inj 1 mg per ml, 10ml vial      Pharmacode 2536463 As of the date of this notification ProPharma / PWR cannot accept Vinblastin Teva Inj for credit under any circumstances. Together we can make this a…

Early Notification & Brand Change Tenofovir disoproxil As advised via Pharmac decision announced 9 March 2018 there is to be a change in the listing and future sole supply. New listing from 1 June 2018 Tenofovir Disoproxil-Teva Tab 300 mg 30                  Pharmacode  2544121               Schedule price $38.10 Incumbent brand Viread Tab 300 mg 30 Gilead                                         Pharmacode 2225972       …

12
Close